In order to achieve the actually excellent healing
prospects of 95 %2 and more, the potential of genetic
diagnostics needs to be exploited. The DNA from
intestinal cells can be extracted, quantified and
analysed for mutations through novel diagnostics.
The following biomarkers help to detect colon
cancer earlier:
• KRAS mutations
• BRAF mutations
• Quantification of human DNA
ColoAlert® is the first stool test to examine patient-
samples for these biomarkers and thus misses up to
73% fewer CRC cases.3,5,7
Comments